Solara Active Pharma Sciences Receives Us Fda Eir For Puducherry
Solara Active Pharma Sciences Receives US FDA EIR For Puducherry ...
Solara Active Pharma Sciences Receives US FDA EIR For Puducherry ...
Solara Active Pharma Sciences Receives US FDA EIR For Puducherry ...
Solara Active Pharma Sciences Receives US FDA EIR For Puducherry ...
Solara Active Pharma Sciences Receives US FDA EIR For Puducherry ...
Solara Active Pharma Sciences Receives US FDA EIR For Puducherry ...
Solara Active Pharma Gets EIR for Puducherry Ibuprofen Plant Post USFDA ...
Solara Active Pharma Sciences Limited - Walk-Ins for Production
Solara Active Pharma Sciences Releases Audited Financial Results for FY ...
&format=webp&quality=medium)
US FDA inspects Vishakhapatnam facility of Solara Active Pharma
Advertisement Space (300x250)
Solara Active Pharma Sciences Receives Funds from Rights Issue ...
Solara Active Pharma Sciences Walk-In Interview for Production API ...
Solara Active Pharma Sciences Publishes Newspaper Ads for Rights Issue ...
US FDA inspects Vishakhapatnam facility of Solara Active Pharma
UDYOG ADDA: Solara Active Pharma Sciences Walk-In Interview for Quality ...
Solara Active Pharma Sciences Walk-In Interview for MSc Chemistry/ B ...
Solara Active Pharma Sciences Limited Receives Income Tax Demand Notice
Solara Clears US FDA Inspection at Puducherry Plant With VAI Status
Solara Active Pharma Sciences Ltd completes yet another USFDA ...
Solara Active Pharma Sciences – A Pure Play API Company
Advertisement Space (336x280)
Solara Announces Successful Closure of US FDA Inspection at Puducherry ...
Solara Active Pharma Sciences Ltd Q4 FY26: Righting the Ship via Rights ...
Solara Active Pharma Sciences Limited, Pondicherry - Manufacturer of ...
US FDA issues Form-483 with zero observations for Solara Active's ...
DSK Legal acts on Rights Issue of Solara Active Pharma Sciences
US FDA issues Form-483 with zero observations for Solara Active's ...
Solara Active Pharma Sciences Q4 Results 2026: Date, Revenue, PAT and ...
Solara Active Pharma Sciences Rights Issue 2024 Date, Price, Allotment ...
.jpg)
Nitte: News from NUCSER | A visit to Solara Active Pharma Sciences
Solara Active Pharma Sciences Limited - Walk-In Interview - 15 and 16 ...
Advertisement Space (336x280)
Solara Active Pharma Sciences Reconstitutes Management Committee Structure
SOLARA ACTIVE PHARMA SCIENCES Q4 FY26: PAT Rs 9.6 Cr
Solara Active Pharma Sciences – A Pure Play API Company
Solara Active Pharma Sciences – A Pure Play API Company
Why Is Solara Active Pharma Sciences Share Price Falling Key Reasons 2026
Solara Active Pharma Sciences Q4 Results 2026: Date, Revenue, PAT ...